Fundraising Fox

Norwich Ventures

Venture capital

Waltham · Seed–Series A · 4 people tracked

Also known as NORWICH VENTURES MANAGEMENT, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Norwich Ventures specializes in early-stage medtech investing, providing initial capital in seed and early-stage rounds to entrepreneurs developing game-changing medical technologies that solve large unmet medical needs. The firm looks for passionate founders, large unmet needs, best-in-class technology, capital efficiency, barriers to entry, and a quick path to proof of concept. It takes a long-term perspective and is agnostic about the field of medicine, having supported companies across electrophysiology, genomics, women's health and more.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Waltham, Massachusetts, US
Instruments
Equity
Founded
2004
Private fund assets
$26.6M
VC funds
1
Tracked investments
12

Team · 4 people

from the firm's website & public directories
Phil Fleck· Advisor (In Memoriam)

Listed on the page as in memoriam.

What they invest in

from 6 of 12 portfolio companies

Biotech ×4Medical Devices ×4Healthtech ×2Advanced Manufacturing ×1Deep Tech ×1Digital Health ×1Hardware ×1

HQs:United States×4

Investments · 12 tracked

founders shown can be your intro path
Boston ScientificNYSE: BSX
MedtronicNYSE: MDT
Daktari DiagnosticsSEC filingmedium confidence

BiotechCambridge, US

Peter Kaspar(Director)Aaron Sandoski(Director)Thierry Bernard(Director)David Rubin(Director)Donald Hawthorne(Executive Officer, Director)

Board seatAaron Sandoski· per SEC Form D · $22.5M raise · filed May 2016

Lexington Medical, Inclexington-med.comin

Lexington Medical manufactures surgical staplers and stapling devices, including the AEON Endostapler for procedures like lung volume reduction surgery.

Advanced ManufacturingHardwareMedical DevicesBedford, US

Jameson Kief(Director of Engineering)David Roberts(Director)Leon Amariglio(Executive Officer, Director)Aaron Sandoski(Director)Doron Harlev(Director)David Lang(Director)

Board seatAaron Sandoski· per SEC Form D

Nanopathnanopath.comin𝕏SEC filingmedium confidence

BiotechCambridge, US

Alison Burklund(Executive Officer, Director)Amogha Tadimety(Executive Officer, Director)

BoardJeff Crowe(Director)

Board seatAaron Sandoski· per SEC Form D · $6M raise · filed Feb 2025

Podimetricspodimetrics.comin

Podimetrics develops a remote monitoring solution combining the SmartMat device and personalized support to identify high-risk individuals with complex diabetes and enable early intervention to prevent complications.

Digital HealthHealthtechMedical DevicesSomerville, US

David Linders(Executive Officer, Director)Jonathan Bloom(Executive Officer, Director)

Board seatAaron Sandoski· per SEC Form D

IONpathionpath.com

IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery.

BiotechDeep TechMedical Devices

Laborie
Qiagen
Tempus
Terumo
vacessvaxess.com

Terrestrial develops the Tacterra microarray patch platform, a dissolvable skin-patch technology for delivering therapies including GLP-1 without injection.

BiotechHealthtechMedical Devices

Rachel Sha(CEO)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

What stage does Norwich Ventures invest at?
Norwich Ventures invests at the Seed, Series A stages.
What sectors does Norwich Ventures focus on?
Norwich Ventures focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices.
Where is Norwich Ventures located?
Norwich Ventures is headquartered in Waltham, US.

Media · Podcasts & interviews

featuring the team

BlankCheck - Aaron Sandoski, Managing Director | Norwich Ventures

pioneerrwjf · Aaron Sandoski

Similar investors

Featured in lists